help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dudás, B.
Right arrow Articles by Merchenthaler, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dudás, B.
Right arrow Articles by Merchenthaler, I.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 6 2946-2953
Copyright © 2002 by The Endocrine Society


Other Original Articles

Close Juxtapositions between LHRH Immunoreactive Neurons and Substance P Immunoreactive Axons in the Human Diencephalon

Bertalan Dudás and István Merchenthaler

Department of Pharmacology and Experimental Therapeutics (B.D.), Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois 60153; and Women’s Health Research Institute (I.M.), Wyeth Research, Collegeville, Pennsylvania 19426

Address all correspondence and requests for reprints to: Istvan Merchenthaler, M.D., D.Sc., Women’s Health Research Institute, Wyeth Research, RN 3164, 500 Arcola Road, Collegeville, Pennsylvania 19426. E-mail: . merchei{at}wyeth.com

Abstract

LHRH release is induced by substance P (SP) in the rat hypothalamus. Recent immunocytochemical studies indicate that SP-immunoreactive axons synapse on LHRH neurons in the diencephalon of the rat, but this phenomenon has not yet been demonstrated in human. Therefore, in the present study we visualized the SP- and LHRH-immunoreactive (IR) elements in the human diencephalon and evaluated the close juxtapositions between them. The distribution of LHRH- and SP-IR sites were investigated in diencephalic sections of six, postmortem human brains by means of double-labeling immunocytochemistry. The LHRH-containing perikarya were located in the diagonal band of Broca, lamina terminalis cinerea, preopticoseptal, medial preoptic, and infundibular areas of the brain. The SP-IR fibers formed a network in the periventricular zone in the infundibular region, median eminence, and corpus striatum. The SP-IR cell bodies were located mainly in the infundibular region, median eminence, basal part of the periventricular area, dorsomedial subdivision of the ventromedial nucleus, and basal perifornical area of the tuberal region. The juxtapositions between LHRH-IR cell bodies and SP-IR varicosities were detected in the infundibular and periventricular regions. In these sites black, silver-intensified, SP-IR fiber varicosities abutted on brown, DAB-labeled, LHRH-IR cell bodies. Similar structures were detected between the SP-IR fibers and SP-IR perikarya. These findings suggest that the juxtapositions between the SP and LHRH systems may be the morphological basis of SP-controlled LHRH release in the human diencephalon. Moreover, the intimate contacts between SP-IR fiber varicosities and SP-IR cell bodies or axons indicate direct control of SP on the diencephalic SP release.

SUBSTANCE P (SP) is an undecapeptide with multiple effects on the cardiovascular (1, 2, 3), gastrointestinal (4, 5), and urinary systems (6, 7) as well as complex central nervous system functions such as learning (8) and memory (9). Previous studies also revealed that SP modulates gonadal functions in several species including human (10, 11, 12, 13, 14, 15, 16, 17). Although the exact mechanism of this modulation is not known, there is a general consensus that this phenomenon is based on the influence of SP on hypophyseal LH release. Because LH secretion from the pituitary gland is under the control of hypothalamic LHRH release, SP can alter gonadal function via direct influence on pituitary LH secretion and/or by regulation of the hypothalamic LHRH system.

For example, SP stimulates LH release from rat (18) and pig (19) pituitary cells in vitro. Moreover, rat anterior pituitary cells both in vivo and in vitro (20, 21, 22) release SP, and SP mRNA has also been detected in the pituitary of humans (23). In addition, the pituitary gland contains SP receptors in both humans (12) and rats (11) suggesting the possibility of direct control by SP on LH secretion. Supporting this type of action, the presence of SP-immunoreactive (IR) fibers in the hypophysial stalk and median eminence has been reported in humans (24) and primates (25). However, there are also contrasting data showing that in dispersed anterior pituitary cells, harvested from estrogen-treated ovariectomized rats, SP did not affect gonadotropin release in vitro (26).

An indirect effect of SP on gonadotropin secretion could be mediated via the LHRH neuronal system. Subcutaneously administered SP inhibits LHRH-induced LH release via NK1 receptors (27, 28), and microinjection of the peptide into the medial preoptic area reduces LH and FSH levels in the plasma (29). A synaptic connection between SP-IR fibers and LHRH-IR cell bodies in the rat has been described by Tsuruo et al. (30), supporting a direct connection between these two neuropeptidergic systems. In vitro, SP inhibits LHRH-stimulated gonadotropin release from rat pituitary cells (28) but potentiates the response in prepubertal porcine cells (19). In contrast to these findings, SP antagonist or antiserum injected into the lateral or third ventricles inhibits LH release (20, 31).

The effect of SP on gonadotropin secretion also depends on the hormonal environment (32, 33). Although iv administration of SP antiserum had no effect on LH or FSH levels of ovariectomized rats, it stimulated LH (but not FSH) secretion in ovariectomized rats with estrogen priming (33). Moreover, iv SP administration directly increases LHRH concentrations in the pituitary portal blood of male rats (34).

Although the LHRH system has already been mapped in the human diencephalon (35), little is known about the pattern of the SP-IR elements. The information on the distribution of SP-IR structures in the brain is based on immunocytochemical studies in rats (36, 37) and humans (24) and in situ hybridization experiments in human tissue samples (38). Because the direct influence of the SP-IR elements on the hypothalamic LHRH system could be the morphological basis for SP-controlled gonadal function, the analysis of the putative juxtapositions between the LHRH- and SP-IR elements might reveal the site of interaction.

In the present study, we mapped LHRH-IR and SP-IR neuronal structures in the human hypothalamus. In an attempt to reveal the location of the putative juxtapositions and to confirm the observations that SP-IR nerve terminals form synaptic contacts on LHRH-IR perikarya in rats (30), the maps of LHRH- and SP-IR images obtained from human brains were superimposed. Finally, the putative synapses between the SP and LHRH immunoreactive elements were identified and quantitated in the overlapping areas using double-label immunohistochemistry.

Materials and Methods

Tissue

Brain samples of three adult women and three adult men (25–72 yr of age) were obtained from autopsies between 24 and 48 h postmortem. Review of the medical records indicated specimens were obtained from individuals with no neurological or neuroendocrinological disease. The brain samples were taken in accordance with the regulations of and with permission from the Ethics Board of the Szent-Györgyi Albert Medical University.

Tissue preparation

Hypothalami were dissected from the brains and immersion fixed in 4% paraformaldehyde/0.1 M phosphate-buffered (pH 7.4) at 4 C for 2–24 wk. Each tissue block contained half of the hypothalamus that was split along the midsagittal line. The samples were cryoprotected in 30% sucrose in phosphate-buffer containing 0.9% sodium chloride (PBS) supplemented with 0.1% sodium-azide and then cut on a Reichert freezing microtome at 30-µm intervals in coronal planes. The sections (~ 450–500 from each block) were collected in a series of four wells into PBS containing 0.2% sodium azide and stored at 4 C until processing. The adjacent sections were processed for Nissl staining with cresyl-violet, immunohistochemical detection of LHRH, immunohistochemical detection of SP, and double-label immunohistochemistry of SP and LHRH.

Immunohistochemistry

Single-labeling immunohistochemistry was carried out using either peroxidase-antiperoxidase (PAP) or streptavidin-biotin methods combined with silver intensification as introduced by Gallyas et al. (39). In brief, samples were pretreated with 10% thioglycolic acid for 30 min and then with 0.2% Triton X-100 for 20 min followed by incubation in 10% normal horse serum in PBS for 1 h at room temperature. Thereafter, the sections were incubated in a primary antiserum solution composed of 10% normal horse serum, PBS, and 0.1% sodium azide for 24 h at 4 C. The LHRH-IR structures were identified using a monoclonal mouse anti-LHRH antiserum (Chemicon, Temecula, CA) at a dilution of 1:20,000. The SP-IR structures were visualized with a rabbit anti-SP serum (7451, Peninsula Laboratories, Inc., San Carlo, CA) at a dilution of 1:50,000. This antiserum was raised against the N-terminal portion of SP, and it shows 100% cross-reactivity with SP and the N-terminus sequence of SP (2–11 but not 7–11). It does not recognize neurokinin A, neurokinin B, neuropeptide K, or physelamin in Western blot analysis. The sections were then incubated for 2 h in a secondary antiserum containing either unlabeled goat antirabbit IgG (Jackson Immunocytochemicals, West Grove, PA) at a dilution of 1:50 for SP, or biotin-labeled horse antimouse IgG (Vector Laboratories, Inc., Burlingame, CA; 1:500) to detect LHRH. In each case, the cross-reactions of the secondary antibodies with the endogenous human IgGs were eliminated by the addition of 2% normal human serum to these reagents. Finally, the sections were incubated for 2 h in rabbit peroxidase-antiperoxidase (Jackson Immunocytochemicals) at a dilution of 1:2,000 for the detection of SP or peroxidase-labeled streptavidin (Jackson Immunocytochemicals) at a dilution of 1:500 for the detection of LHRH. The chromogen solution was composed of 0.05% diamino-benzidine (DAB), 0.125% nickel-ammonium-sulfate, and 0.005% hydrogen-peroxide in 0.1 M Tris-HCl (pH 7.6). The resulting DAB polymer was silver intensified in a solution containing 0.1% silver nitrate, 0.1% ammonium-nitrate, 1% silicotungstic acid, and 0.2% formaldehyde for 3–4 min (39).

Simultaneous detection of SP- and LHRH-IR structures was performed using double-label immunohistochemistry. First, SP immunohistochemistry was carried out as described above using DAB/nickel chromogen, and then the LHRH-IR neuronal structures were immunolabeled with DAB alone as described above (39, 40). For dual labeling the anti-LHRH serum was used in a 1:8000 dilution.

Because it was not practical to perform electron microscopic analysis on tissue obtained after a 24- to 48-h postmortem period, some of the double-labeled sections were embedded in plastic to obtain thin (0.5 µm) sections. Thus, the large frozen sections were cut in smaller pieces, processed through graded ethanol series and propylene oxide, and then flat embedded in Durcupan (Sigma, St. Louis, MO). Semithin sections were cut with an ultramicrotome (Reichert).

In control sections, the primary antibodies were omitted or replaced by nonimmune rabbit serum at the dilution of 1:50,000 (SP) or 1:20,000 (LHRH), respectively. In both cases, immunoreaction was not observed. In addition, the SP antiserum used in these studies was preabsorbed with SP (Peninsula Laboratories, Inc.). Preabsorption with as low as 10 µg/ml of the working dilution of the primary antiserum completely eliminated the staining. According to the distributor (Peninsula Laboratories, Inc.), the antiserum is specific for SP and does not cross-react with other members of the tachykinin family, including neurokinin A, neurokinin B, or physelamin in Western blot analysis.

Data analysis

The hypothalamic sections were systematically scanned with the aid of a plain scanner (Hewlett-Packard Co., Palo Alto, CA). The outlines of the sections were traced using CorelTrace software 4.0 (Corel Corp., Ottawa, Ontario, Canada). The computer-generated superimposition of eight consecutive sections were summarized in each of the slides shown in Fig. 1Go. The neurons and fibers were marked on these figures using an Axiophot microscope with camera lucida (Carl Zeiss, Thornwood, NY) and Adobe Photoshop software, version 3.0.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Distribution of LHRH-IR perikarya (dots) and SP-IR (circles, perikarya; lines, fibers) structures in coronal sections of the human diencephalon. Each slide (A–P) is the superimposition of eight 30-µm-thick sections. Ac, Anterior commissure; Fx, fornix; Och, optic chiasm; Ot, optic tract; Pvn, paraventricular nucleus; Mb, mamillary body; Son, supraoptic nucleus. Scale bar, 5000 µm.

 
Terminology

The terminology of the diencephalic structures was adapted from Braak and Braak (41), Saper (42), and Silverman et al. (35).

Results

LHRH-IR system

The pattern of the LHRH-IR neuronal elements was similar to our previous immunohistochemical study (43, 44). LHRH-IR cell bodies were concentrated in the ventral and caudal part of the periventricular zone, mainly in the medial preoptic, infundibular areas, and the median eminence. Few cells were found along the diagonal band of Broca and in either the paraventricular or supraoptic nuclei. The majority of LHRH-IR neurons were fusiform, although a few multipolar cells (less than 5% of the total population) were found in the medial preoptic area. Immunoreactive fibers were located in the diagonal band of Broca and periventricular and infundibular areas. No differences related to sex, age, and/or postmortem time were observed in the number and/or pattern of IR perikarya and processes.

SP-IR system

The majority (94%) of the SP-IR perikarya were located in the tuberal region. Only a few cell bodies were seen scattered in the periventricular zone of the preoptic area and basal part of the posterior hypothalamus. In the tuberal region, the neurons were arranged in several subclasses. Most of the perikarya were found in the infundibular region (Figs. 1Go and 2Go, H–J) and the median eminence (Fig. 2Go, K and L). The basal part of the periventricular area and the dorsomedial subdivision of the ventromedial nucleus contained an additional cell population (Figs. 1Go and 2Go, H–J). Neither the paraventricular nor supraoptic nuclei contained any SP-IR perikarya (Figs. 1Go and 2Go, F–I). Finally, a well-defined cell group was distinguished in the basal perifornical area of the tuberal region (Figs. 1Go and 2Go, H–J).



View larger version (24K):
[in this window]
[in a new window]
 
Figure 2. Distribution of LHRH-IR perikarya (dots) and SP-IR (circles, perikarya; lines, fibers) structures in coronal sections of the human diencephalon. Each slide (A–P) is the superimposition of eight 30-µm-thick sections. Ac, Anterior commissure; Fx, fornix; Och, optic chiasm; Ot, optic tract; Pvn, paraventricular nucleus; Mb, mamillary body; Son, supraoptic nucleus. Scale bar, 5000 µm.

 
Morphologically, the SP-IR neurons could be classified into two subtypes: fusiform or multipolar cells. The majority of the cells were fusiform, with oval-shaped cell bodies with a process emanating from each of the poles (Fig. 3BGo). The multipolar cells, with triangle-shaped or rounded cell bodies, were usually situated in the dorsomedial subdivision of the ventromedial nucleus (Fig. 3AGo).



View larger version (93K):
[in this window]
[in a new window]
 
Figure 3. SP-IR neural elements in the human diencephalon. A, Multipolar cell in the dorsomedial subdivision of the ventromedial nucleus. B, Silver-intensified SP-IR fiber varicosities abut on fusiform, SP-IR cell bodies in the infundibular nucleus. The juxtapositions of SP-IR elements are denoted by arrowheads. C, The portal vessels in the infundibular region are surrounded by SP-IR fiber varicosities. Scale bar, 20 µm.

 
SP-IR fibers formed a loose network throughout the diencephalon. In the septal area, few fiber varicosities were seen along the diagonal band of Broca (Fig. 1Go, A and B) and around the anterior comissure (Fig. 1Go, C and D). In the preoptic area, SP-IR fibers were mainly periventricularly arranged, and a delicate fiber network appeared around the fornix (Fig. 1Go, E and F). In the lateral zone of the preoptic area, SP-IR processes were located in the corpus striatum and on the basal part of the diencephalon running parallel with the surface of the brain (Fig. 1Go, E and F). The supraoptic nuclei did not contain significant amounts of SP-IR fibers (Fig. 1Go, F–H). Most of the fiber varicosities were periventricularly arranged in the tuberal region of the diencephalon. Dense network of fibers was located around the portal vessels in the infundibulum/pituitary stalk (Fig. 3CGo). Few axons were detected in the paraventricular nucleus (Figs. 1Go and 2Go, G–I). An additional SP-IR fiber population was distinguished running to the infundibulum and the median eminence, passing over the optic tract and located laterally on the basal region of the diencephalon (Figs. 1Go and 2Go, H–L). Numerous SP-IR processes were located around the fornix in the tuberal region (Figs. 1Go and 2Go, I–L). In the posterior hypothalamus, the axon varicosities were found at the base of the third ventricle and in the periventricular area (Fig. 2Go, M–P). On the lateral part of the posterior hypothalamus, SP-IR fibers were observed at the region of the corpus striatum (Fig. 2Go, M–P). No sex- and age-related differences were observed in the number and/or pattern of SP-IR perikarya and processes, and the different postmortem periods did not influence the number of IR structures.

Juxtapositions between the LHRH and SP elements

Superimposing the map of the LHRH- and SP-IR neural elements revealed that the two systems were overlapped in the medial preoptic area, in the infundibulum and median eminence (Figs. 1Go and 2Go, F–L). Partial overlap was detected in the periventricular zone of the tuberal region and in the paraventricular nucleus (Figs. 1Go and 2Go, G–K). Dual-labeling immunohistochemistry in these areas revealed that LHRH-IR cell bodies were contacted by SP-IR fiber varicosities. Closer examination with high magnification revealed black, silver-intensified SP-IR fiber varicosities abutted on brown, diaminobenzidine-labeled LHRH-IR cell bodies in the medial preoptic area, basal part of the periventricular zone in the tuberal region, infundibulum, and median eminence (Fig. 4Go). None of these juxtapositions were detected in the paraventricular nucleus. All hypothalami contained a similar distribution of LHRH-SP contacts irrespective of sex or age.



View larger version (123K):
[in this window]
[in a new window]
 
Figure 4. Juxtapositions between the SP (black) and LHRH (brown) IR structures in the human diencephalon. The position of the demonstrated LHRH-IR neurons is shown by asterisks in the upper corners of the micrographs. The schematic drawings correspond to the slices denoted by the same letters in Fig. 1Go. The thickness of the sections is 30 µm (A and B and D–G), and that of the plastic section is 0.5 µm (C). Scale bar, 10 µm.

 
Quantitation of the LHRH-SP juxtapositions showed that majority of these structures (67%) were located in the infundibular area and median eminence. In these regions, 18% of the LHRH-IR perikarya were heavily innervated (more than three intimate contacts), 37% were lightly (one to three intimate contacts) innervated by SP-IR fibers, while 45% were not closely associated with SP-IR axon terminals. LHRH-SP juxtapositions were detected also in the medial preoptic area (12%) and in the periventricular zone of the tuberal region (21%). Here the LHRH-IR perikarya contacted to one to three SP-IR axon varicosities (Fig. 4Go).

Juxtapositions between the SP elements

In addition to the SP-LHRH connections, several SP-IR axons contacted SP-IR cell bodies or axons in the infundibular nucleus (Fig. 3BGo). The structure of these juxtapositions was similar to those between the LHRH-IR and SP-IR elements.

Discussion

Previous studies revealed that SP regulates gonadal functions by influencing LH release from the pituitary gland (13, 14, 20, 28, 29, 31, 32). Although the mechanism of this phenomenon is not entirely known, it is generally believed that SP might regulate LH secretion by affecting hypothalamic LHRH synthesis and/or release. In the present study, we mapped the LHRH and SP systems and reported evidences of juxtapositions between LHRH and SP-IR elements. These intimate contacts between the two systems may be synapses as suggested by others (30) that provide the morphological basis for SP regulation of gonadal function.

The pattern and morphology of LHRH-IR elements in the present study agrees with our previous findings (43, 44). LHRH-IR perikarya were present mainly along the diagonal band of Broca and in the medial preoptic area, infundibulum, and median eminence. In addition, the distribution of LHRH-IR neuronal elements was not affected by sex or age. Earlier studies reported SP-IR structures in the diencephalon of the rat (24, 25); however, little is known about the distribution and morphology of SP-IR structures in the human brain. Although the distribution of SP mRNA-expressing neurons in the human brain is similar to the distribution of SP-IR cell bodies, probably because of the sensitivity of the in situ hybridization technique, the number of SP mRNA-expressing cells is higher (38). The present study provides a high-resolution map of the SP-IR elements in the entire human hypothalamus. Interestingly, the location of SP-IR cell bodies was almost entirely restricted to the tuberal region of the diencephalon, whereas SP-IR fiber varicosities were widely distributed in the hypothalamus. These data suggest that a significant amount of SP-IR axons may have an extrahypothalamic origin, and they may play role in the regulation of several diencephalic functions.

In the tuberal region, SP-IR perikarya were found mainly in the infundibular area and median eminence, surrounded by a dense network of SP-IR fiber varicosities. This finding corresponds to earlier studies reporting SP in the median eminence of the rat (24, 25). Moreover, Wormald et al. (12) reported SP receptors in the human pituitary and found that SP acting at the level of the pituitary inhibits LHRH-induced LH secretion in man. Similar to the studies of Hökfelt et al. (25) and Mai et al. (24), in our studies also, a close relationship between the SP-IR structures and the portal vessels was detected, suggesting direct control of SP on the release of pituitary hormones in human.

Additional subgroups of SP-IR perikarya were located in the basal part of the periventricular zone, dorsomedial subdivision of the ventromedial nucleus, and in the basal perifornical area of the tuberal region. Although these cell bodies seemed to project toward the median eminence, their location and the wide distribution of SP-IR fibers in the diencephalon indicate that certain SP-IR structures may not have direct contact with the portal vessels. These data support the theory that SP may control other diencephalic functions as well.

Previous studies reported that microinjection of SP into the medial preoptic area, or SP antagonist or antiserum injected into the lateral and third ventricles, influence plasma LH and/or FSH levels in rats (20, 30, 32). These effects of SP are believed to be mediated by regulation of hypothalamic LHRH secretion, suggesting that the subpopulation of LHRH neurons close to the ventricles may be involved in SP-controlled LH release. This theory was supported by superimposing the maps of LHRH and SP-IR systems in humans. These superimposed images showed that the LHRH and SP-IR elements overlap mainly in the periventricular area of the tuberal region, infundibular region, and median eminence. Here LHRH cell bodies are surrounded by dense SP-IR fiber varicosities. Close examination of dual-labeled sections found that LHRH-IR perikarya in these areas revealed that individual LHRH-IR elements were in contact with the axonal swellings of two or more SP-IR fibers. Analysis of 0.5-µm-thick plastic sections did not reveal any gap between the contacting elements. These data suggest direct SP control on hypothalamic LHRH release in these regions and suggest that the juxtapositions between the LHRH-IR and SP-IR elements are functional synapses. Similar intimate contacts were detected between SP-IR fiber varicosities and SP-IR cell bodies or axons, indicating direct control of SP-IR elements on the diencephalic SP release.

Our earlier studies reported close contacts between the LHRH-IR and NPY-IR (43) or catecholaminergic (44) elements in the medial preoptic region, infundibular area, and median eminence. The similar morphology and pattern of LHRH and NPY/catecholaminergic juxtapositions and those between LHRH-IR and SP-IR elements suggest that some of the SP-IR axon varicosities might contain NPY or catecholamines as well. Therefore, these systems may interact at the diencephalic level and regulate complex functions. The putative interaction of the NPY, catecholaminergic, and SP systems with LHRH-IR neurons in the medial preoptic and infundibular area/median eminence raises the possibility that other neuromodulator systems may influence hypothalamic LHRH release at the same sites. Thus, LHRH secretion is the result of an interaction with several neural inputs on the LHRH-IR cells. Because LHRH-IR perikarya located in the septal area, lamina terminalis cinerea, lateral preoptic area, paraventricular, supraoptic, and lateral part of the posterior hypothalamus do not seem to receive inputs from NPY/catecholaminergic/SP systems, the function of LHRH neurons in these subgroups of nuclei and the control of the LHRH release may be entirely different in these sites. Alternatively, it is possible that the release of LHRH by NPY/catecholaminergic/SP systems also takes place in the median eminence.

In conclusion, the juxtapositions reported here between the LHRH- and SP-IR elements may be the morphological substrate for the SP-controlled regulation of gonadal functions in human. A direct interaction between SP and LHRH systems, as first suggested by Tsuruo et al. (30) based on electron microscopic observations in rats, may take place at the level of LHRH perikarya and dendrites in the medial preoptic area and infundibular stalk/median eminence regions. Intimate contacts between the SP-IR elements indicate that SP release may be directly controlled by juxtaposing SP-IR structures. Moreover, the wide distribution of SP-IR fiber varicosities in the hypothalamus suggests that SP controls other diencephalic functions as well.

Acknowledgments

We thank Prof. Zsolt Liposits (Hungarian Academy of Sciences, Budapest, Hungary) and Dr. Tammy Dellovade (Women’s Health Research Institute, Wyeth-Ayerst Research, Radnor, PA) for critical evaluation of the data and Gabriella Kovács for expert technical assistance.

Footnotes

Abbreviations: DAB, Diamino-benzidine; IR, immunoreactive; SP, substance P.

Received August 23, 2001.

Accepted February 26, 2002.

References

  1. Bury RW, Mashford ML 1977 Cardiovascular effects of synthetic substance P in several species. Eur J Pharmacol 45:335–340[CrossRef][Medline]
  2. Hasséssian H, Prat A, De Champlain J, Couture R 1991 Regulation of cardiovascular sympathetic neurons by substance P and gamma-aminobutyric acid in the rat spinal cord. Eur J Pharmacol 202:51–60[CrossRef][Medline]
  3. Itoi K, Jost N, Badoer E, Tschöpe C, Culman J, Unger T 1991 Localization of the substance P-induced cardiovascular responses in the rat hypothalamus. Brain Res 558:123–126[CrossRef][Medline]
  4. Holzer P 1985 Stimulation and inhibition of gastrointestinal propulsion induced by substance P and substance K in the rat. Br J Pharmacol 86:305–312[Medline]
  5. Rosell S 1980 Substance P and neurotensin in the control of gastrointestinal function. Soc Gen Physiol Ser 35:147–162[Medline]
  6. Kramer HJ, Klingmuller D, Flachskampf FA, Dusing R 1983 Substance P-induced changes in kidney function in the conscious rat: relation to the renal prostaglandin system. Ren Physiol 6:10–18[Medline]
  7. Andersson KE 1999 Advances in the pharmacological control of the bladder. Exp Physiol 84:195–213[Abstract]
  8. Staubli U, Huston JP 1979 Differential effects on learning by ventromedial vs. lateral hypothalamic posttrial injection of substance P. Pharmacol Biochem Behav 10:783–786[CrossRef][Medline]
  9. Tomaz C, Nogueira PJ 1997 Facilitation of memory by peripheral administration of substance P. Behav Brain Res 83:143–145[CrossRef][Medline]
  10. Antonowicz U, Jakubowska-Naziemblo B, Cannon D, Powell D 1982 Immunoreactive substance P content in median eminence and pituitary gland during oestrus, dioestrus and after anterior hypothalamic deafferentation. Endokrinologie 79:25–34[Medline]
  11. Kerdelhue B, Tartar A, Lenoir V, el Abed A, Hublau P, Millar RP 1985 Binding studies of substance P anterior pituitary binding sites: changes in substance P binding sites during the rat estrous cycle. Regul Pept 10:133–143[CrossRef][Medline]
  12. Wormald PJ, Millar RP, Kerdelhue B 1989 Substance P receptors in human pituitary: a potential inhibitor of luteinizing hormone secretion. J Clin Endocrinol Metab 69:612–615[Abstract/Free Full Text]
  13. Coiro V, Volpi R, Capretti L, Caiazza A, Marcato A, Bocchi R, Colla R, Rossi G, Chiodera P 1992 Luteinizing hormone response to an intravenous infusion of substance P in normal men. Metabolism 41:689–691[CrossRef][Medline]
  14. Traczyk WZ, Pau KY, Kaynard AH, Spies HG 1992 Modulatory role of substance P on gonadotropin and prolactin secretion in the rabbit. J Physiol Pharmacol 43:279–297[Medline]
  15. Angelova P, Davidoff MS, Bakalska M, Kanchev L 1996 In vitro effects of substance P and arginine-vasopressin on testosterone production in Leydig cells of short and long photoperiodic hamsters. Andrologia 28:321–326[Medline]
  16. Kerdelhue B, Gordon K, Williams R, Lenoir V, Fardin V, Chevalier P, Garret C, Duval P, Kolm P, Hodgen G, Jones H, Jones GS 1997 Stimulatory effect of a specific substance P antagonist (RPR 100893) of the human NK1 receptor on the estradiol-induced LH and FSH surges in the ovariectomized cynomolgus monkey. J Neurosci Res 50:94–103[CrossRef][Medline]
  17. Gobbetti A, Petrelli C, Zerani M 2000 Substance P downregulates basal and gonadotropin-releasing hormone-induced gonadotropin in vitro secretion by pituitary gland of crested newt, Triturus carnifex. J Neuroendocrinol 12:1160–1166[CrossRef][Medline]
  18. Shamgochian MD, Leeman SE 1992 Substance P stimulates luteinizing hormone secretion from anterior pituitary cells in culture. Endocrinology 131:871–875[Abstract/Free Full Text]
  19. Hidalgo-Diaz C, Castano JP, Lopez-Pedrera R, Malagon MM, GarciaNavarro S, Gracia-Navarro F 1998 A modulatory role for substance P on the regulation of luteinizing hormone secretion by cultured porcine gonadotrophs. Biol Reprod 58:678–685[Abstract/Free Full Text]
  20. Morel G, Chayvialle JA, Kerdelhue B, Dubois PM 1982 Ultrastructural evidence for endogenous substance-P-like immunoreactivity in the rat pituitary gland. Neuroendocrinology 35:86–92[Medline]
  21. Aronin N, Morency K, Leeman SE, Braverman LE, Coslovsky R 1984 Regulation by thyroid hormone of the concentration of substance P in the rat anterior pituitary. Endocrinology 114:2138–2142[Abstract/Free Full Text]
  22. DePalatis LR, Khorram O, Ho RH, Negro-Vilar A, McCann SM 1984 Partial characterization of immunoreactive substance P in the rat anterior pituitary gland. Life Sci 34:225–238[CrossRef][Medline]
  23. Byrne JM, Jones PM, Hill SF, Bennet WM, Ghatei MA, Bloom SR 1992 Expression of messenger ribonucleic acids encoding neuropeptide-Y, substance-P, and vasoactive intestinal polypeptide in human pituitary. J Clin Endocrinol Metab 75:983–987[Abstract]
  24. Mai JK, Stephens PH, Hopf A, Cuello JM 1986 Substance P in the human brain. Neuroscience 17:709–839[CrossRef][Medline]
  25. Hökfelt T, Pernow B, Nilsson G, Wetterberg L, Goldstein M, Jefcoate SL 1978 Dense plexus of substance P immunoreactive terminals in eminentia mediana of the primate hypothalamus. Proc Natl Acad Sci USA 75:1013–1015[Abstract/Free Full Text]
  26. Arisawa M, De Palatis L, Ho R, Snyder GD, Yu WH, Pan G, McCann SM 1990 Stimulatory role of substance P on gonadotropin release in ovariectomized rats. Neuroendocrinology 51:523–529[Medline]
  27. Battmann T, Melik Parsadaniantz S, Jeanjean B, Kerdelhue B 1991 In vivo inhibition of the preovulatory LH surge by substance P and in vitro modulation of gonadotrophin-releasing hormone-induced LH release by substance P, oestradiol and progesterone in the female rat. J Endocrinol 130:169–175[Abstract/Free Full Text]
  28. Duval P, Lenoir V, Garret C, Kerdelhue B 1996 Reduction of the amplitude of preovulatory LH and FSH surges and of the amplitude of the in vitro GnRH-induced LH release by substance P. Reversal of the effect by RP 67580. Neuropharmacology 35:1805–1810[CrossRef][Medline]
  29. Picanco-Diniz DL, Valenca MM, Franci CR, Antunes-Rodrigues J 1990 Role of substance P in the medial preoptic area in the regulation of gonadotropin and prolactin secretion in normal or orchidectomized rats. Neuroendocrinology 51:675–682[Medline]
  30. Tsuruo Y, Kawano H, Hisano S, Kagotani Y, Daikoku S, Zhang T, Yanaihara N 1991 Substance P-containing neurons innervating LHRH-containing neurons in the septo-preoptic area of rats. Neuroendocrinology 53:236–245[Medline]
  31. Dees WL, Skelley CW, Kozlowski GP 1985 Central effects of an antagonist and an antiserum to substance P on serum gonadotropin and prolactin secretion. Life Sci 37:1627–1631[CrossRef][Medline]
  32. Duval P, Lenoir V, Kerdelhue B 1998 The in vitro effect of substance P on the GnRH-induced LH release depends on the steroidal environment and is reverted by a NK1 receptor antagonist (RP 67580) in the cycling female rat. Neuropeptides 32:97–101[CrossRef][Medline]
  33. Evans JJ 1999 Modulation of gonadotropin levels by peptides acting at the anterior pituitary gland. Endocr Rev 20:46–67[Abstract/Free Full Text]
  34. Walczewska A, Szkudlarek U, Jakubowska-Naziemblo B, Dziedzic B, Traczyk WZ 1998 Increase of gonadotropin-releasing hormone concentration in pituitary portal blood after substance P administration in male rats. Neuroendocrinology 67:219–227[CrossRef][Medline]
  35. Silverman AJ, Livne I, Witkin JW 1994 The gonadotropin-releasing hormone (GnRH), neuronal systems: immunocytochemistry and in situ hybridization. In: Knobil E, Neill JD, eds. The physiology of reproduction. New York: Raven Press; 1683–1709
  36. Sakanaka M, Shiosaka S, Takatsuki K, Inagaki S, Takagi H, Senba E, Kawai Y, Matsuzaki T, Tohyama M 1981 Experimental immunohistochemical studies on the amygdalofugal peptidergic (substance P and somatostatin) fibers in the stria terminalis of the rat. Brain Res 221:231–242[CrossRef][Medline]
  37. Jakubowska-Naziemblo B, Antonowicz U, Cannon D, Powell D, Rohde W 1985 Immunoreactive substance P and LH-RH content in median eminence and pituitary gland during proestrus, oestrus, lactation and after anterior hypothalamic deafferentation. Exp Clin Endocrinol 85:155–166[Medline]
  38. Chawla MK, Guterrez GM, Young III WS, McMullen NT, Rance NE 1997 Localization of neurons expressing substance P and neurokinin B gene transcripts in the human hypothalamus and basal forebrain. J Comp Neurol 384:429–442[CrossRef][Medline]
  39. Gallyas F, Görcs T, Merchenthaler I 1982 High-grade intensification of the end-product of the diaminobenzidine reaction for peroxidase histochemistry. J Histochem Cytochem 30:183–184[Abstract]
  40. Streit P, Reubi JC 1977 A new and sensitive staining method for axonally transported horseradish peroxidase (HRP) in the pigeon visual system. Brain Res 126:530–537[CrossRef][Medline]
  41. Braak H, Braak E 1987 The hypothalamus of the human adult: chiasmatic region. Anat Embryol (Berl) 175:315–330[CrossRef][Medline]
  42. Saper CB 1990 Hypothalamus. In: Paxinos G, ed. The human nervous system. San Diego: Academic Press; 389–413
  43. Dudas B, Mihaly A, Merchenthaler I 2000 Topography and associations of luteinizing hormone-releasing hormone and neuropeptide Y-immunoreactive neuronal systems in the human diencephalon. J Comp Neurol 427:593–603[CrossRef][Medline]
  44. Dudas B, Merchenthaler I 2001 Catecholaminergic axons innervate luteinizing hormone-releasing hormone neurons of the human diencephalon. J Clin Endocrinol Metab 86:5620–5626[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
BrainHome page
A.-M. Bao, A. Hestiantoro, E. J. W. Van Someren, D. F. Swaab, and J.-N. Zhou
Colocalization of corticotropin-releasing hormone and oestrogen receptor-{alpha} in the paraventricular nucleus of the hypothalamus in mood disorders
Brain, June 1, 2005; 128(6): 1301 - 1313.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Hestiantoro and D. F. Swaab
Changes in Estrogen Receptor-{alpha} and -{beta} in the Infundibular Nucleus of the Human Hypothalamus Are Related to the Occurrence of Alzheimer's Disease Neuropathology
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1912 - 1925.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Dudas and I. Merchenthaler
Topography and Associations of Leu-Enkephalin and Luteinizing Hormone-Releasing Hormone Neuronal Systems in the Human Diencephalon
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1842 - 1848.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Dudas and I. Merchenthaler
Close Juxtapositions between Luteinizing Hormone-Releasing Hormone-Immunoreactive Neurons and Corticotropin-Releasing Factor-Immunoreactive Axons in the Human Diencephalon
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5778 - 5784.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dudás, B.
Right arrow Articles by Merchenthaler, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dudás, B.
Right arrow Articles by Merchenthaler, I.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals